Periodic Reporting for period 2 - MEL-PLEX (Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine)

In the absence of personalised and optimised treatment, great numbers of cancer patients suffer from inefficient therapies. Malignant melanoma exemplifies a largely chemotherapy-resistant, highly heterogeneous and aggressive cancer. Novel treatment options for personalised...